Literature DB >> 15041591

The effects of propofol on hypothalamic paraventricular nucleus neurons in the rat.

Tetsuro Shirasaka1, Yasuhiro Yoshimura, De-Lai Qiu, Mayumi Takasaki.   

Abstract

UNLABELLED: The mechanism of hypotension induced by anesthetics is not completely understood. Because no electrophysiologic examination of the effects of propofol on the central nervous system has shown its involvement in the control of sympathetic and cardiovascular functions, we investigated the actions of propofol on rat hypothalamic paraventricular nucleus (PVN) neurons using the whole-cell mode of the patch-clamp technique in rat hypothalamic PVN slice preparations. Propofol induced Cl(-) currents at concentrations of 10(-5) and 10(-4) M, which were sensitive to picrotoxin and, to a lesser extent, to strychnine. Propofol (10(-6) M) enhanced gamma-aminobutyric acid(A) (GABA(A); 10(-6) M)-induced current synergistically. Moreover, propofol (10(-5) and 10(-4) M) significantly increased the decay time of evoked-inhibitory postsynaptic currents, which suggests a postsynaptic modulation of GABA(A) receptors. In addition, propofol (10(-5), 10(-4), and 2 x 10(-4) M) reversibly inhibited voltage-gated Ca(2+) currents. Taken together, these results suggest that propofol enhancement of GABA(A)-receptor mediated currents and inhibition of voltage-gated Ca(2+) currents at the central level, which is involved in the control of cardiovascular and sympathetic functions may be, at least in part, involved in general anesthetic-induced cardiovascular and sympathetic depression. IMPLICATIONS: We investigated the actions of propofol on the rat hypothalamic paraventricular nucleus neurons, which are involved in the control of cardiovascular and sympathetic functions. The results suggest that propofol enhancement of gamma-aminobutyric acid(A)-receptor mediated currents and inhibition of voltage-gated Ca(2+) currents at the central level may be, at least in part, involved in general anesthetic-induced cardiovascular and sympathetic depression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15041591     DOI: 10.1213/01.ane.0000107960.89818.35

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  7 in total

1.  Effect of intravenous anesthetic propofol on synaptic vesicle exocytosis at the frog neuromuscular junction.

Authors:  Luciana Ferreira Leite; Renato Santiago Gomez; Matheus de Castro Fonseca; Marcus Vinicius Gomez; Cristina Guatimosim
Journal:  Acta Pharmacol Sin       Date:  2010-11-29       Impact factor: 6.150

2.  Effects of orexin-A on propofol anesthesia in rats.

Authors:  Tetsuro Shirasaka; Tetsu Yonaha; Shin Onizuka; Isao Tsuneyoshi
Journal:  J Anesth       Date:  2010-12-10       Impact factor: 2.078

3.  Propofol enhances both tonic and phasic inhibitory currents in second-order neurons of the solitary tract nucleus (NTS).

Authors:  Stuart J McDougall; Timothy W Bailey; David Mendelowitz; Michael C Andresen
Journal:  Neuropharmacology       Date:  2007-11-07       Impact factor: 5.250

4.  Behavior and cellular evidence for propofol-induced hypnosis involving brain glycine receptors.

Authors:  Hai T Nguyen; Ke-yong Li; Ralph L daGraca; Ellise Delphin; Ming Xiong; Jiang H Ye
Journal:  Anesthesiology       Date:  2009-02       Impact factor: 7.892

5.  Association of Polymorphisms in Pharmacogenetic Candidate Genes with Propofol Susceptibility.

Authors:  Qi Zhong; Xiangdong Chen; Yan Zhao; Ru Liu; Shanglong Yao
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

6.  Intravenous Anesthetic, Propofol Affects Synaptic Responses in Cerebellar Purkinje Cells.

Authors:  Kwan Young Lee; Yujin Jang; Min Hee Lee; Young Im Kim; Sung-Cherl Jung; Seung-Yun Han; Se Hoon Kim; Hyung Seo Park; Dong Kwan Kim
Journal:  Clin Psychopharmacol Neurosci       Date:  2018-05-31       Impact factor: 2.582

7.  Novel Expression of GABAA Receptors on Resistance Arteries That Modulate Myogenic Tone.

Authors:  Peter D Yim; George Gallos; Steven A Lee-Kong; William Dan; Amy D Wu; Dingbang Xu; Dan E Berkowitz; Charles W Emala
Journal:  J Vasc Res       Date:  2020-02-25       Impact factor: 1.934

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.